Answers are grounded in this paper and cite their sources.
Background/Objective: The lactate-to-prealbumin ratio (LPR) has been proposed as a potential prognostic marker in sepsis. However, its prognostic performance compared with the lactate-to-albumin ratio (LAR) has not been established in older patients. This study compared LPR and LAR with respect to their association with 28-day mortality and discriminatory performance in older patients with sepsis and elevated lactate. Methods: This single-center retrospective cohort study included patients aged ≥75 years with sepsis and an initial serum lactate concentration of ≥2.0 mmol/L. The primary outcome was 28-day mortality. Prognostic performance was evaluated using Kaplan–Meier, Cox proportional hazards, and receiver operating characteristic (ROC) curve analyses. Exploratory subgroup analyses were performed according to age (≥86 years) and initial lactate concentration (>4 mmol/L). Results: Among 72 patients, 57 survived and 15 died within 28 days. Non-survivors had higher LAR and LPR values than survivors; serum lactate concentrations did not differ significantly between the groups. High LPR was associated with lower 28-day survival probability (log-rank p = 0.002) and remained significantly associated with mortality after adjustment for Sequential Organ Failure Assessment (SOFA) score (hazard ratio [HR], 4.90; 95% confidence interval [CI], 1.06–22.58; p = 0.042), whereas high LAR did not (HR, 1.60; 95% CI, 0.54–4.74; p = 0.401). The area under the ROC curve (AUC) was 0.785 for LPR and 0.702 for LAR, with a marginally significant difference between the two (DeLong test, p = 0.049). In the subgroup aged ≥86 years, the AUC was higher for LPR than for LAR (0.770 vs. 0.663; p = 0.043), whereas no significant difference was observed in patients with lactate concentrations >4 mmol/L (0.807 vs. 0.789; p = 0.834). Conclusions: In older patients with sepsis and an initial lactate concentration of ≥2.0 mmol/L, LPR showed a slightly higher discriminatory performance for 28-day mortality than LAR and remained independently associated with mortality after adjustment for SOFA score. These findings suggest a potential prognostic advantage of LPR over LAR in this specific population. Further validation in larger multicenter cohorts is warranted.
No takes yet. Share an insight, caveat, or question.
Hirayama et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: